Articles in Press [16 articles]

• Health-Related Quality of Life, treatment satisfaction, adherence and persistence in ß-Thalassemia and Myelodysplastic Syndrome patients with iron overload receiving deferasirox: results from the EPIC clinical trial, John B. Porter, Donald Bowden, Marina Economou, Jacques Troncy, A. Ganser, Dany Habr, Nicolas Martin, Adam Gater, Diana Rofail, Linda N. Abetz, Helen Lau, and Maria Cappellini
• Foetal haemoglobin (HbF) , Erythrocytes containing foetal haemoglobin (F cells) and haematological features in Congolese patients with sickle cell anaemia, Léon TSHILOLO, Valentina Summa, Chiara Gregorj, Claude Kinsiama, Jacques Aimé Bazeboso, Giuseppe Avvisati, and Dominique Labie
• An Epidemiological Study of Anemia and Renal Dysfunction in Patients Admitted to ICUs across the United States, Donald F Brophy, Spencer E Harpe, Daniel Carl, and Gretchen Brophy
• Induction of Fetal Hemoglobin in Vivo Mediated by a Synthetic ?-Globin Zinc Finger Activator, Flavia Costa, Halyna Fedosyuk, Renee Neades, Johana Bravo de Los Rios, Carlos F. Barbas, and Kenneth R. Peterson
• Sickling cells, cyclic nucleotides and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia, Mario Angelo Claudino and Kleber Yotsumoto Fertrin
• Integrating Interactive Web-Based Technology to Assess Adherence and Clinical Outcomes in Pediatric Sickle Cell Disease, Lori Crosby Lori, Ilana Barach, Meghan McGrady, Karen Kalinyak, Adryan Eastin, and Monica J. Mitchell
• Physiopathology of bone modifications in beta-thalassemia, Carlo Perisano, Emanuele Marzetti, Maria Silvia Spinelli, Cinzia Anna Maria Callà, Calogero Graci, and Giulio Maccauro
• Hematopoietic Stem Cell Function in a Murine model of Sickle Cell Disease, Elisabeth Javazon, Mohamed Radhi, Bagirath Gangadharan, Jennifer Perry, and David Archer
• Loss of Ercc1 results in a time- and dose-dependent reduction of proliferating early hematopoietic progenitors., Judith H.E. Verhagen-Oldenampsen, Jurgen R. Haanstra, Paulina M.H. van Strien, Marijke Valkhof, Ivo P. Touw, and Marieke von Lindern
• A DOG’s view of Fanconi anemia: Insights from C. elegans, Martin R Jones and Ann M Rose
• A Dutch Fanconi anemia FANCC founder mutation in Canadian Manitoba Mennonites, Yne Waterham-de Vries, Nikki Lwiwski, Marieke Levitus, Bertus Kuyt, Sara J. Israels, Fré Arwert, Christian M. Zwaan, Cheryl R. Greenberg, Blanche P. Alter, Hans Joenje, and Hanne Meijers-Heijboer
• Diagnosis of Fanconi anemia. III. Mutation analysis by next-generation sequencing, Najim Ameziane, Daoud Sie, Stefan Dentro, Lianne Kerkhoven, Johan J. Gille, Hans Joenje, Erik A. Sistermans, Johan P. de Winter, Yavuz Ariyurek, Josephine C. Dorsman, and Bauke Ylstra
• Diagnosis of Fanconi anemia. II. Mutation analysis by multiplex ligation-dependent probe amplification (MLPA) and PCR-based Sanger sequencing, Johan J. Gille, Karijn Floor, Lianne Kerkhoven, Najim Ameziane, Hans Joenje, and Johan P. de Winter
• Fanconi anemia proteins and their interacting partners: A molecular puzzle, Tagrid Kaddar and Madeleine Carreau
• Evaluation of Hematological Parameters in Partial exchange and Packed Cell Transfusion in Treatment of Severe Anemia in Pregnancy, Sudha Salhan, Vrijesh Tripathi, Rajvir Singh, and Harsha S. Gaikwad
• Spatiotemporal Dysfunction of the Vascular Permeability Barrier in Transgenic Mice with Sickle Cell Disease, Samit Ghosh, Fang Tan, and Solomon F. Ofori-Acquah